Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0000932440-03-000354
Filing Date
2003-11-21
Accepted
2003-11-21 16:29:28
Documents
1
Group Members
ALAIN SCHREIBERJAY MOORINJOYCE TSANGPASQUALE DEANGELISPROQUEST ASSOCIATES II LLCPROQUEST ASSOCIATES LLCPROQUEST COMPANION FUND, L.P.PROQUEST INVESTMENTS II ADVISORS FUND, L.P.PROQUEST INVESTMENTS II, L.P.

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13G AMENDMENT NO. 1 point_asciisch13g.txt SC 13G/A 33310
  Complete submission text file 0000932440-03-000354.txt   35702
Mailing Address 125 SUMMER STREET BOSTON MA 02110
Business Address 125 SUMMER STREET BOSTON MA 02110 6179332130
POINT THERAPEUTICS INC (Subject) CIK: 0000919745 (see all company filings)

EIN.: 043216862 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-46114 | Film No.: 031018531
SIC: 2834 Pharmaceutical Preparations

Mailing Address
Business Address 600 ALEXANDER PARK SUITE 204 PRINCETON NJ 08540 6099193567
PROQUEST INVESTMENTS LP (Filed by) CIK: 0001224924 (see all company filings)

EIN.: 043428180 | State of Incorp.: DE | Fiscal Year End: 1231